Pharma

How Adapt Pharma tackled the opioid crisis head on

How Adapt Pharma tackled the opioid crisis head on

By

The firm's Narcan product is more than just a lifesaving treatment for opioid overdose. It's a brilliant, salient campaign, as well.

Shortening the drug side-effect list, and five other ways pharma DTC is set to be reformed

Shortening the drug side-effect list, and five other ways pharma DTC is set to be reformed

By

MM&M hosted an event in Boston devoted to discussing topics and trends for the DTC marketer.

The MM&M buyer's guide to boutique consulting services

The MM&M buyer's guide to boutique consulting services

You've seen what the biggies can do. What about the smaller end of the spectrum? MM&M's second buyer's guide to pharma, healthcare, and life sciences consulting services focuses on the dos and don'ts of hiring boutique firms.

Interview | Scott Dulitz, TrialCard

Interview | Scott Dulitz, TrialCard

By

Scott Dulitz, SVP, Corporate Strategy, Business Development for TrialCard, outlines how embracing the modern hub allows brands to reach their full potential.

ePharma: Boehringer Ingelheim and Aptus Health partner for asthma brand awareness

ePharma: Boehringer Ingelheim and Aptus Health partner for asthma brand awareness

Jim Boushie, director of respiratory marketing at Boehringer Ingelheim (BI) and David Laros, VP of analytics and commercial effectiveness at Aptus Health, came together to lead a joint ePharma session in March titled "Synchronized HCP and consumer campaigns: At the point of care and beyond."

What's the state of diversity in healthcare agencies?

What's the state of diversity in healthcare agencies?

By

The 2018 MM&M/Publicis Health Diversity Survey is open.

High-profile candidates challenge marketers well in advance of launch

High-profile candidates challenge marketers well in advance of launch

By

With pharma facing ongoing scrutiny of its pricing practices, medical marketers are increasingly asked to demonstrate the superior value of new therapies. High-profile candidates in immunology, pain management, and melanoma challenge marketers well in advance of launch.

Marketers discuss catalysts for use of behavioral science techniques

Marketers discuss catalysts for use of behavioral science techniques

By

Marketers discuss the biggest catalysts for use of behavioral science techniques in marketing.

Dr. Reddy's Laboratories CEO of developed markets Alok Sonig makes Wall Street listen

Dr. Reddy's Laboratories CEO of developed markets Alok Sonig makes Wall Street listen

By

Alok Sonig, chief executive officer of developed markets at Dr. Reddy's Laboratories, articulates the benefits of generics.

Standing out in the era of value-based healthcare marketing

Standing out in the era of value-based healthcare marketing

With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.

DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

By

Following massive strikes by Opdivo and Keytruda, will more supersized campaigns follow?

DTC ads 2017: The good, the bad, and the ugly

DTC ads 2017: The good, the bad, and the ugly

By

We considered pharma and healthcare ads that, per iSpotTV, started airing no earlier than January 2017.

HealthSpark 2018 unites disruptors at SXSW

HealthSpark 2018 unites disruptors at SXSW

AI, wearables, and VR still reign supreme in the healthcare realm, and other things you missed

 Five things for pharma marketers to know: Friday, March 30, 2018

Five things for pharma marketers to know: Friday, March 30, 2018

By

Walmart and Humana have started acquisition talks; Blue Cross and Blue Shield says opioids should not be the first treatment option to manage pain

The Cambridge Analytica mess: What does it mean for pharma?

The Cambridge Analytica mess: What does it mean for pharma?

What happens in the world of Facebook cannot be ignored in pharma marketing. It increasingly lives in a world of data that is highly sensitive and must be managed well.

Five things for pharma marketers to know: Thursday, March 29, 2018

Five things for pharma marketers to know: Thursday, March 29, 2018

PhRMA has released a series of new ads that blame high drug prices on cost increases to insurers and PBMs; Veterans Affairs Secretary Dr. David Shulkin has been fired; UK biotech Redx has suspended a Phase I/II trial of its cancer drug

Will PBMs take heat for high drug prices?

Will PBMs take heat for high drug prices?

PBMs began by providing a huge service to payers, but in recent years, they've begun to suck revenue from pharma manufacturers. Will they take some heat for high drug prices?

Will the real patient advocate please stand up?

Will the real patient advocate please stand up?

By

Industry opponents say the end is nigh for pharma's ability to deduct expenses for consumer drug advertising, but those who've found their calling in healthcare comms ought to have something to say about that.

Rbb Communications forms Healthcare Advisory Council

Rbb Communications forms Healthcare Advisory Council

By

The council, made up of seasoned pharma execs, will function as consultants to rbb's health clients and health team.

McCaskill takes aim at DTC ad tax deduction; measure expected to face stiff resistance

McCaskill takes aim at DTC ad tax deduction; measure expected to face stiff resistance

Pharma companies are likely to put up aggressive resistance to the measure, introduced earlier this month.

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

By

The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.

 MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

By

MM&M has announced its annual showcase of executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.

Rise of the health-tech ethicist

Rise of the health-tech ethicist

Want to get an ethicist agitated? Mention the integration of voice-activation and other tech into healthcare. Experts say navigating this area is a work in progress.

Pharma CMO: Why We're Being Blinded by Our Brands

Pharma CMO: Why We're Being Blinded by Our Brands

Recently, Forbes ran an article from Wild Pixel Media founder and CEO Carlos Machicao lamenting the fact that healthcare advertising is boring.

Xbox for Docs: Pharma backs AR games for use in physician learning

Xbox for Docs: Pharma backs AR games for use in physician learning

By

Pharma has backed a number of AR-based games for physician learning and marketing. They're meant to complement live learning, but mobile games may do a better job teaching certain skills.

Teva rebrands in North America amid global restructuring

Teva rebrands in North America amid global restructuring

By

The pharmaceutical company is undergoing a global restructuring as it relaunches its brand in the U.S. and Canada.

Purdue's Point of No Return

Purdue's Point of No Return

By

Purdue's decision to pull OxyContin sales reps highlights what has been the biggest part of marketing budgets. Did we just see the tipping point?

Sanofi revamps web presence as part of Empowering Life campaign

Sanofi revamps web presence as part of Empowering Life campaign

By

The company is also looking to better combine its web and social media presence.

Five things for pharma marketers to know: Tuesday, February 13, 2018

Five things for pharma marketers to know: Tuesday, February 13, 2018

By

Amazon moves into medical supply market; Big Pharma gets a tax cut; Former Celgene CEO plans Senate run.

Infographic | Highlighting top healthcare trends

Infographic | Highlighting top healthcare trends

By

There was so much bigger-picture coverage of pharma and healthcare in 2017 - pricing, Affordable Care Act reform and repeal - that it was easy to lose sight of everything else. PwC's Health Research Institute has used its annual look-ahead report to spotlight a handful of undercover trends.